Receptor systems participating in nicotine-specific effects

被引:52
作者
Sziráki, I [1 ]
Sershen, H [1 ]
Benuck, M [1 ]
Hashim, A [1 ]
Lajtha, A [1 ]
机构
[1] Nathan S Kline Inst Psychiat Res, Ctr Neurochem, Orangeburg, NY 10962 USA
关键词
D O I
10.1016/S0197-0186(98)00049-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It is generally accepted that self-administration of drugs is prompted primarily by a reward system driven by an increase in extracellular dopamine in the nucleus accumbens. Recent findings that dopamine increase in the accumbens can be caused by many other factors, among them stress, suggest a more complex mechanism, and possibly differences in the reward system for different compounds. In the present paper we compare the effects of receptor-specific antagonists on the increase of dopamine induced by nicotine with that induced by cocaine in the nucleus accumbens in conscious rats. The compounds alone or together were injected intravenously, and dopamine level changes were measured via microdialysis. When administered together the effect of nicotine and cocaine on the level of dopamine in the accumbens was additive. Apparently there is some interaction between the two compounds, since nicotine had no effect after combined nicotine and cocaine administration. Perhaps the available dopamine pool was exhausted by the prior administration. The nicotinic antagonist mecamylamine, the muscarinic antagonist atropine, and the NMDA glutamate receptor antagonist MK-801 each blocked nicotine-induced dopamine release in the accumbens, indicating the participation of more than a single receptor system in the nicotine-induced effect. These three antagonists did not inhibit cocaine-induced dopamine increase in the accumbens, indicating the lack of a role of these receptors in the cocaine effect under our experimental conditions. SCH-23390, a dopamine D-1 receptor antagonist, blocked both nicotine- and cocaine-induced effects, indicating the possible role of this receptor in these reward effects. The results indicate that there are differences in some of the receptors mediating the central effects of the two compounds examined, nicotine and cocaine, although each influences dopamine levels, and that the two compounds interact. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:445 / 457
页数:13
相关论文
共 58 条
[1]   Nicotinic acetylcholine receptors in the rat and primate nucleus tractus solitarius and on rat and human inferior vagal (nodose) ganglia:: Evidence from in vivo microdialysis and [125I]α-bungarotoxin autoradiography [J].
Ashworth-Preece, M ;
Jarrott, B ;
Lawrence, AJ .
NEUROSCIENCE, 1998, 83 (04) :1113-1122
[2]   Neuropharmacological mechanisms of drug reward: Beyond dopamine in the nucleus accumbens [J].
Bardo, MT .
CRITICAL REVIEWS IN NEUROBIOLOGY, 1998, 12 (1-2) :37-67
[3]   Acute intermittent nicotine treatment produces regional increases of basic fibroblast growth factor messenger RNA and protein in the tel- and diencephalon of the rat [J].
Belluardo, N ;
Blum, M ;
Mudo, G ;
Andbjer, B ;
Fuxe, K .
NEUROSCIENCE, 1998, 83 (03) :723-740
[4]   Accumbal dopamine overflow after ethanol: Localization of the antagonizing effect of mecamylamine [J].
Blomqvist, O ;
Ericson, M ;
Engel, JA ;
Soderpalm, B .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 334 (2-3) :149-156
[5]   Acute effects of cocaine on human brain activity and emotion [J].
Breiter, HC ;
Gollub, RL ;
Weisskoff, RM ;
Kennedy, DN ;
Makris, N ;
Berke, JD ;
Goodman, JM ;
Kantor, HL ;
Gastfriend, DR ;
Riorden, JP ;
Mathew, RT ;
Rosen, BR ;
Hyman, SE .
NEURON, 1997, 19 (03) :591-611
[6]   Effect of MK-801 at the human alpha 7 nicotinic acetylcholine receptor [J].
Briggs, CA ;
McKenna, DG .
NEUROPHARMACOLOGY, 1996, 35 (04) :407-414
[7]   Open-channel blockers at the human α4β2 neuronal nicotinic acetylcholine receptor [J].
Buisson, B ;
Bertrand, D .
MOLECULAR PHARMACOLOGY, 1998, 53 (03) :555-563
[8]  
CAINE SB, 1995, BRAIN RES, V692, P47
[9]  
Chang JY, 1998, J NEUROSCI, V18, P3098
[10]   Release of [H-3]-noradrenaline from rat hippocampal synaptosomes by nicotine: Mediation by different nicotinicreceptor subtypes from striatal [H-3]-dopamine release [J].
Clarke, PBS ;
Reuben, M .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 117 (04) :595-606